-
-
-
-
-
-
-
RBC Capital: 'On balance we think readthroughs from the GSK acquisition of NUVB's key competitor are positive'
-
-
-
-
-
-
-
Truist Reiterates Buy Rating on Nuvation Bio Inc (NUVB) as 'Ibtrozi Momentum Builds'
-
-
-
-
-
-
-
Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 2c
-
-
-
-
-
-
-
Nuvation Bio partners with Eisai for taletrectinib in Europe
-
-
-
-
-
-
-
Nuvation Bio Inc (NUVB) PT Raised to $10 at Citizens on Safusidenib Plans
-
-
-
-
-
-
-
Nuvation Bio gets Japan approval for lung cancer drug IBTROZI
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
-
443,903 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

